IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Contra Mirati Therapeu NPV from 60468T105

CUSIP: 604CVR027 | 8 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Sterling Capital Management LLC109
0.0% of portfolio›$0
Ascentis Independent Advisors2
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Sterling Capital Management LLC
109$00.0%CoreMediumCharlotte, NC2026-10-22
Ascentis Independent Advisors
2$00.0%GrowthLowDallas, TX2026-11-03